• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GPR101 通过组成型激活 G 和 G 驱动小鼠生长激素分泌过多和巨人症。

GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of G and G.

机构信息

Laboratory of Molecular Pharmacology, GIGA-Molecular Biology of Diseases, University of Liège, Liège, Belgium.

Department of Endocrinology, Centre Hospitalier Universitaire de Liège, University of Liège, Liège, Belgium.

出版信息

Nat Commun. 2020 Sep 21;11(1):4752. doi: 10.1038/s41467-020-18500-x.

DOI:10.1038/s41467-020-18500-x
PMID:32958754
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7506554/
Abstract

Growth hormone (GH) is a key modulator of growth and GH over-secretion can lead to gigantism. One form is X-linked acrogigantism (X-LAG), in which infants develop GH-secreting pituitary tumors over-expressing the orphan G-protein coupled receptor, GPR101. The role of GPR101 in GH secretion remains obscure. We studied GPR101 signaling pathways and their effects in HEK293 and rat pituitary GH3 cell lines, human tumors and in transgenic mice with elevated somatotrope Gpr101 expression driven by the rat Ghrhr promoter (Ghrhr). Here, we report that Gpr101 causes elevated GH/prolactin secretion in transgenic Ghrhr mice but without hyperplasia/tumorigenesis. We show that GPR101 constitutively activates not only G, but also G and G, which leads to GH secretion but not proliferation. These signatures of GPR101 signaling, notably PKC activation, are also present in human pituitary tumors with high GPR101 expression. These results underline a role for GPR101 in the regulation of somatotrope axis function.

摘要

生长激素(GH)是生长的关键调节剂,GH 过度分泌可导致巨人症。其中一种形式是 X 连锁肢端巨大症(X-LAG),婴儿会在过度表达孤儿 G 蛋白偶联受体 GPR101 的情况下发展为分泌 GH 的垂体肿瘤。GPR101 在 GH 分泌中的作用仍不清楚。我们研究了 GPR101 信号通路及其在 HEK293 和大鼠垂体 GH3 细胞系、人类肿瘤以及由大鼠 Ghrhr 启动子(Ghrhr)驱动的升高的生长激素细胞 Gpr101 表达的转基因小鼠中的作用。在这里,我们报告 Gpr101 导致转基因 Ghrhr 小鼠中的 GH/催乳素分泌升高,但没有增生/肿瘤发生。我们表明 GPR101 不仅持续激活 G,还激活 G 和 G,这导致 GH 分泌而不是增殖。GPR101 信号的这些特征,特别是 PKC 激活,也存在于高表达 GPR101 的人类垂体肿瘤中。这些结果强调了 GPR101 在调节生长激素细胞轴功能中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7b/7506554/a509f5058478/41467_2020_18500_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7b/7506554/834a56133009/41467_2020_18500_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7b/7506554/8364b72c930f/41467_2020_18500_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7b/7506554/142df66662d7/41467_2020_18500_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7b/7506554/6a9eacf50204/41467_2020_18500_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7b/7506554/a38b00e4a119/41467_2020_18500_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7b/7506554/86c7d52a2ae9/41467_2020_18500_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7b/7506554/19250e301a4f/41467_2020_18500_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7b/7506554/a509f5058478/41467_2020_18500_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7b/7506554/834a56133009/41467_2020_18500_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7b/7506554/8364b72c930f/41467_2020_18500_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7b/7506554/142df66662d7/41467_2020_18500_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7b/7506554/6a9eacf50204/41467_2020_18500_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7b/7506554/a38b00e4a119/41467_2020_18500_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7b/7506554/86c7d52a2ae9/41467_2020_18500_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7b/7506554/19250e301a4f/41467_2020_18500_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7b/7506554/a509f5058478/41467_2020_18500_Fig8_HTML.jpg

相似文献

1
GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of G and G.GPR101 通过组成型激活 G 和 G 驱动小鼠生长激素分泌过多和巨人症。
Nat Commun. 2020 Sep 21;11(1):4752. doi: 10.1038/s41467-020-18500-x.
2
Gigantism: X-linked acrogigantism and GPR101 mutations.巨人症:X连锁肢端巨大症与GPR101突变
Growth Horm IGF Res. 2016 Oct-Dec;30-31:64-69. doi: 10.1016/j.ghir.2016.09.007. Epub 2016 Sep 29.
3
The Genetic Pathophysiology and Clinical Management of the TADopathy, X-Linked Acrogigantism.X 连锁肢端巨大症的遗传病理生理学和临床管理
Endocr Rev. 2024 Sep 12;45(5):737-754. doi: 10.1210/endrev/bnae014.
4
Screening for genetic causes of growth hormone hypersecretion.筛查生长激素分泌过多的遗传原因。
Growth Horm IGF Res. 2016 Oct-Dec;30-31:52-57. doi: 10.1016/j.ghir.2016.10.004. Epub 2016 Oct 12.
5
An orphan G-protein-coupled receptor causes human gigantism and/or acromegaly: Molecular biology and clinical correlations.孤儿 G 蛋白偶联受体导致人类巨人症和/或肢端肥大症:分子生物学和临床相关性。
Best Pract Res Clin Endocrinol Metab. 2018 Apr;32(2):125-140. doi: 10.1016/j.beem.2018.02.004. Epub 2018 Mar 17.
6
Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study.胚系或体细胞 GPR101 重复导致 X 连锁肢端巨大症:临床病理和遗传学研究。
Acta Neuropathol Commun. 2016 Jun 1;4(1):56. doi: 10.1186/s40478-016-0328-1.
7
Duplications disrupt chromatin architecture and rewire GPR101-enhancer communication in X-linked acrogigantism.重复序列破坏染色质结构,并重新连接 X 连锁肢端巨大症中的 GPR101 增强子通讯。
Am J Hum Genet. 2022 Apr 7;109(4):553-570. doi: 10.1016/j.ajhg.2022.02.002. Epub 2022 Feb 23.
8
GPR101: Modeling a constitutively active receptor linked to X-linked acrogigantism.GPR101:建模与 X 连锁肢端巨大症相关的组成性激活受体。
J Mol Graph Model. 2024 Mar;127:108676. doi: 10.1016/j.jmgm.2023.108676. Epub 2023 Nov 21.
9
X-Linked AcrogigantismX连锁肢端巨大症
10
Case report: Management of pediatric gigantism caused by the TADopathy, X-linked acrogigantism.病例报告:X 连锁肢端巨大症导致的儿童巨人症的治疗。
Front Endocrinol (Lausanne). 2024 Feb 28;15:1345363. doi: 10.3389/fendo.2024.1345363. eCollection 2024.

引用本文的文献

1
Non-penetrant Xq26.3 duplication involving the invariant TAD border: clinical evidence for the VGLL1 region as the GPR101 pituitary enhancer of X-linked acrogigantism.涉及不变TAD边界的非渗透性Xq26.3重复:VGLL1区域作为X连锁肢端肥大症的GPR101垂体增强子的临床证据。
Pituitary. 2025 Jul 20;28(4):85. doi: 10.1007/s11102-025-01559-4.
2
GPR101 loss promotes insulin resistance and diet-induced obesity risk.GPR101缺失会增加胰岛素抵抗和饮食诱导的肥胖风险。
Neurosci Appl. 2023 Apr 19;2:101126. doi: 10.1016/j.nsa.2023.101126. eCollection 2023.
3
Distinguishing benign from pathogenic duplications involving and -adjacent enhancers in the clinical setting with the bioinformatic tool POSTRE.

本文引用的文献

1
Single-cell transcriptomic analysis of adult mouse pituitary reveals sexual dimorphism and physiologic demand-induced cellular plasticity.单细胞转录组分析揭示成年小鼠垂体的性别二态性和生理需求诱导的细胞可塑性。
Protein Cell. 2020 Aug;11(8):565-583. doi: 10.1007/s13238-020-00705-x. Epub 2020 Mar 19.
2
Familial X-Linked Acrogigantism: Postnatal Outcomes and Tumor Pathology in a Prenatally Diagnosed Infant and His Mother.家族性 X 连锁肢端巨大症:产前诊断的婴儿及其母亲的围产期结局和肿瘤病理学。
J Clin Endocrinol Metab. 2019 Oct 1;104(10):4667-4675. doi: 10.1210/jc.2019-00817.
3
Growth Hormone Discovery and Structure.
使用生物信息学工具POSTRE在临床环境中区分涉及和相邻增强子的良性与致病性重复。
medRxiv. 2025 Jul 10:2025.06.27.25329768. doi: 10.1101/2025.06.27.25329768.
4
Comparing models and experimental structures of the GPR101 receptor: Artificial intelligence yields highly accurate models.比较GPR101受体的模型与实验结构:人工智能生成高度精确的模型。
J Mol Graph Model. 2025 Nov;140:109103. doi: 10.1016/j.jmgm.2025.109103. Epub 2025 Jun 3.
5
Exploration of Hub Genes and Immune Cell Infiltration Characteristics Associated With Spinal Cord Injury in Mice.小鼠脊髓损伤相关枢纽基因及免疫细胞浸润特征的探索
J Inflamm Res. 2025 Feb 20;18:2613-2628. doi: 10.2147/JIR.S499402. eCollection 2025.
6
GHRH and the prostate.生长激素释放激素与前列腺
Rev Endocr Metab Disord. 2024 Nov 7. doi: 10.1007/s11154-024-09922-9.
7
Spliceosome component TCERG1 regulates the aggressiveness of somatotroph adenoma.剪接体成分TCERG1调节生长激素腺瘤的侵袭性。
J Endocrinol Invest. 2025 Feb;48(2):333-344. doi: 10.1007/s40618-024-02447-7. Epub 2024 Oct 3.
8
Chromatin conformation capture in the clinic: 4C-seq/HiC distinguishes pathogenic from neutral duplications at the GPR101 locus.临床中的染色质构象捕获:4C-seq/HiC 可区分 GPR101 基因座上致病性与中性重复。
Genome Med. 2024 Sep 13;16(1):112. doi: 10.1186/s13073-024-01378-5.
9
Unlocking the Genetic Secrets of Acromegaly: Exploring the Role of Genetics in a Rare Disorder.揭开肢端肥大症的遗传奥秘:探索遗传学在一种罕见疾病中的作用。
Curr Issues Mol Biol. 2024 Aug 20;46(8):9093-9121. doi: 10.3390/cimb46080538.
10
G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery.G 蛋白偶联受体(GPCRs):结构、机制和药物发现方面的进展。
Signal Transduct Target Ther. 2024 Apr 10;9(1):88. doi: 10.1038/s41392-024-01803-6.
生长激素的发现与结构
Pediatr Endocrinol Rev. 2018 Sep;16(Suppl 1):2-10. doi: 10.17458/per.vol16.2018.bbk.ghdiscoverystructure.
4
The causes and consequences of pituitary gigantism.垂体巨大症的病因和后果。
Nat Rev Endocrinol. 2018 Dec;14(12):705-720. doi: 10.1038/s41574-018-0114-1.
5
The G protein-coupled receptors deorphanization landscape.G 蛋白偶联受体的非孤儿化全景。
Biochem Pharmacol. 2018 Jul;153:62-74. doi: 10.1016/j.bcp.2018.02.016. Epub 2018 Feb 15.
6
Activation of the Orphan G Protein-Coupled Receptor GPR27 by Surrogate Ligands Promotes -Arrestin 2 Recruitment.替代配体激活孤儿G蛋白偶联受体GPR27可促进β-抑制蛋白2的募集。
Mol Pharmacol. 2017 Jun;91(6):595-608. doi: 10.1124/mol.116.107714. Epub 2017 Mar 17.
7
Purinergic Receptor Transactivation by the -Adrenergic Receptor Increases Intracellular Ca in Nonexcitable Cells.β-肾上腺素能受体对嘌呤能受体的反式激活增加非兴奋性细胞内的钙离子浓度
Mol Pharmacol. 2017 May;91(5):533-544. doi: 10.1124/mol.116.106419. Epub 2017 Mar 9.
8
Conformational Profiling of the AT1 Angiotensin II Receptor Reflects Biased Agonism, G Protein Coupling, and Cellular Context.AT1血管紧张素II受体的构象分析反映了偏向性激动、G蛋白偶联和细胞环境。
J Biol Chem. 2017 Mar 31;292(13):5443-5456. doi: 10.1074/jbc.M116.763854. Epub 2017 Feb 17.
9
Identification and pharmacological characterization of succinate receptor agonists.琥珀酸受体激动剂的鉴定及药理学特性研究
Br J Pharmacol. 2017 May;174(9):796-808. doi: 10.1111/bph.13738. Epub 2017 Mar 10.
10
Diabetes in Patients With Acromegaly.肢端肥大症患者的糖尿病
Curr Diab Rep. 2017 Feb;17(2):8. doi: 10.1007/s11892-017-0838-7.